Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease.

Rihwa Choi Mi-Na Lee Kyunga Kim Sun Young Baek Tae Jun Kim Sung Noh Hong Young-Ho Kim Soo-Youn Lee

Published in: British journal of clinical pharmacology (2020)

The results of this study may help clinicians to understand the effects of other various polymorphisms in addition to TPMT and NUDP15 in thiopurine metabolism for management of Crohn's disease patients.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
palliative care
type diabetes
peritoneal dialysis
patient reported outcomes
metabolic syndrome
insulin resistance
weight loss
replacement therapy
smoking cessation